Target intelligence / Profile preview

Intestinal epithelial cell surface binding proteins

Molecular classification
Receptor, Enzyme, Transporter, Cell adhesion molecule, Other
01

Overview

Intestinal epithelial cell surface binding proteins (IEC-SBPs) represent a heterogeneous group of proteins located on the apical membrane of enterocytes that facilitate the interaction between the host and the luminal environment. This category includes various molecular entities such as receptors (e.g., Guanylate cyclase-C), transporters (e.g., PEPT1, SGLT1), and enzymes (e.g., Aminopeptidase N), which are vital for nutrient absorption, fluid homeostasis, and immune surveillance (Abreu, 2010; Waldman & Camilleri, 2018). These proteins also serve as critical attachment sites for enteric pathogens, including bacteria like Escherichia coli and various viruses, which exploit them to initiate infection (Ribet & Cossart, 2015). In the pharmaceutical industry, these proteins are targeted by drugs such as linaclotide to treat gastrointestinal motility disorders or are utilized in the design of oral vaccines and targeted drug delivery systems to enhance mucosal immunity and drug bioavailability (Maeda et al., 2013). Because the term describes a functional class rather than a specific molecular target, it is considered a broad category in pharmacological research. The expression and function of these proteins are often modulated by the gut microbiota and inflammatory states, influencing both health and disease.

Other names
Enterocyte surface binding proteinsIntestinal brush border receptorsApical membrane binding proteinsIntestinal epithelial cell surface proteins
02

Mechanism of action

Agonism of surface receptors to modulate fluid secretion, inhibition of transporters to manage electrolyte balance, or blocking of adhesion sites to prevent infection.

03

Biological functions

Cell adhesionNutrient transportImmune responsePathogen recognitionSignal transduction
04

Disease associations

InfectionInflammationIrritable bowel syndromeMalabsorption
05

Safety considerations

Diarrhea and electrolyte imbalanceDisruption of the intestinal barrierAlteration of the gut microbiomeMalabsorption of essential nutrients
06

Interacting drugs

Linaclotide

5 more in the full profile.

07

Biomarkers

Guanylate cyclase-C (GUCY2C) expressionFecal calprotectinZonulinPEPT1 expression levels

Beyond the preview

Go deeper on Intestinal epithelial cell surface binding proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell surface binding proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call